(Q35575099)

8 August 2017

1 reference

title

Nutritional status in the neuroendocrine control of growth hormone secretion: the model of anorexia nervosa (English)

1 reference

8 August 2017

0 references

Massimo Scacchi

1

1 reference

8 August 2017

Angela Ida Pincelli

series ordinal

2

1 reference

8 August 2017

Francesco Cavagnini

series ordinal

3

1 reference

8 August 2017

publication date

1 July 2003

1 reference

Frontiers in Neuroendocrinology

8 August 2017

published in

1 reference

8 August 2017

volume

24

1 reference

8 August 2017

issue

3

1 reference

8 August 2017

page(s)

200-224

1 reference

The growth hormone secretagogue, L-692,429, induces phosphatidylinositol hydrolysis and hormone secretion by human pituitary tumors

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Obesity-associated decrease in growth hormone-releasing hormone gene expression: a mechanism for reduced growth hormone mRNA levels in genetically obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Weight in the balance

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Evidence for a direct pituitary inhibition by free fatty acids of in vivo growth hormone responses to growth hormone-releasing hormone in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Acute pharmacologic blockade of lipolysis normalizes nocturnal growth hormone levels and pulsatility in obese subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Update on female pubertal development

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: effect of short- and long-term weight recuperation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effects of GHRP-2 and Hexarelin, Two Synthetic GH-Releasing Peptides, on GH, Prolactin, ACTH and Cortisol Levels in Man. Comparison with the Effects of GHRH, TRH and hCRH

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Mechanisms underlying the negative growth hormone (GH) autofeedback on the GH-releasing effect of hexarelin in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Endocrine Activities of Ghrelin, a Natural Growth Hormone Secretagogue (GHS), in Humans: Comparison and Interactions with Hexarelin, a Nonnatural Peptidyl GHS, and GH-Releasing Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

The effects of growth hormone (GH)-releasing peptides on GH secretion in perifused pituitary cells of adult male rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Potentiation of cholinergic tone counteracts the suppressive effect of oral glucose administration on the GH response to GHRH in man

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

The role of VIP and somatostatin in the control of GH and prolactin release in anorexia nervosa and in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Body composition in acromegaly.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Acquired growth hormone resistance in patients with hypercatabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Role of selected endogenous peptides in growth hormone-releasing hexapeptide activity: analysis of growth hormone-releasing hormone, thyroid hormone-releasing hormone, and gonadotropin-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Metabolic actions of growth hormone: direct and indirect

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Characterization of insulin-like growth factor I receptors in the median eminence of the brain and their modulation by food restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Reduced ob mRNA in hypophysectomised rats is not restored by growth hormone (GH), but further suppressed by exogenously administered insulin-like growth factor (IGF) I.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

On the actions of the growth hormone-releasing hexapeptide, GHRP.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Plasma concentrations of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha in anorexia and bulimia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Alpha 2-adrenoceptor sensitivity in anorexia nervosa: GH response to clonidine or GHRH stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Clonidine stimulation in anorexia nervosa: growth hormone, cortisol, and beta-endorphin responses

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Plasma concentrations of interleukin-1-beta, interleukin-6 and tumor necrosis factor-alpha, and of their soluble receptors and receptor antagonist in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Peculiar body composition in patients with Prader-Labhart-Willi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

The somatotrophic axis in young steers: influence of nutritional status and oestradiol-17 beta on hepatic high- and low-affinity somatotrophic binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effects of food deprivation on the GH axis: immunocytochemical and molecular analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Growth hormone-releasing factor-induced growth hormone secretion from perifused rat anterior pituitary cells: lack of influence of glucose concentration, and normal responses in pituitary cells from diabetic animals

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Growth hormone-releasing peptides and their analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Regulation of in vivo growth hormone secretion by leptin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Role of growth hormone (GH)-releasing hormone and somatostatin on leptin-induced GH secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A Review

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Growth hormone and prolactin secretion after growth hormone-releasing hormone administration, in anorexia nervosa patients, normal controls and tamoxifen-pretreated volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Serum immunoreactive leptin concentrations in patients with anorexia nervosa before and after partial weight recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Response of ACTH and cortisol to corticotropin-releasing hormone in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Somatostatin withdrawal as generator of pulsatile GH release in the dog: a possible tool to evaluate the endogenous GHRH tone?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3',5'-monophosphate accumulation in rat primary pituitary cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

A novel non-peptidyl growth hormone secretagogue.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Augmentation by propranolol of growth hormone-releasing hormone-(1-44)-NH2-induced growth hormone release in normal short and normal children

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Neuroendocrine immune features of pediatric inflammatory rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Reduction of plasma immunoreactive somatomedin C during fasting in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Growth hormone administration conserves lean body mass during dietary restriction in obese subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Growth hormone therapy in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Oral glucose inhibits growth hormone secretion induced by human pancreatic growth hormone releasing factor 1-44 in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Differential effects of feeding on the ultradian variation of the growth hormone (GH) response to GH-releasing hormone in normal subjects and patients with obesity and anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Influence of naloxone infusion on prolactin and growth hormone response to growth hormone-releasing hormone in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effects of galanin on growth hormone and prolactin secretion in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Role of food intake in the modulation of hexarelin-induced growth hormone release in normal human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Opioid dysregulation in anorexia nervosa: naloxone effects on preprandial and postprandial growth hormone response to growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Defective hypothalamic growth hormone (GH)-releasing hormone activity may contribute to declining GH secretion with age in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Interaction of glucose and pyridostigmine on the secretion of growth hormone (GH) induced by GH-releasing hormone (GHRH).

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Hypothalamo-pituitary-adrenal axis and growth hormone axis in patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

GH-deficient dw/dw rats and lit/lit mice show increased Fos expression in the hypothalamic arcuate nucleus following systemic injection of GH-releasing peptide-6

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Growth hormone alters lipolysis and hormone-sensitive lipase activity in 3T3-F442A adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Growth hormone regulation of the expression of differentiation-dependent genes in preadipocyte Ob1771 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Food fails to suppress ghrelin levels in obese humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Regulation of lipolysis and leptin biosynthesis in rodent adipose tissue by growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Growth hormone and prolactin secretion in genetically obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

L-arginine-induced growth hormone secretion is not influenced by co-infusion of the nitric oxide synthase inhibitor N-monomethyl- L-arginine in healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Hypothalamic-pituitary function in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Cytokine-mediated growth hormone release from cultured ovine pituitary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Endocrine and non-endocrine activities of growth hormone secretagogues in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Arginine but not pyridostigmine, a cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Adrenocorticotropin- and Cortisol-Releasing Effect of Hexarelin, a Synthetic Growth Hormone-Releasing Peptide, in Normal Subjects and Patients with Cushing's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Arginine potentiates the GHRH- but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effects of Recombinant Human Insulin-Like Growth Factor I Administration on Growth Hormone (GH) Secretion, Both Spontaneous and Stimulated by GH-Releasing Hormone or Hexarelin, a Peptidyl GH Secretagogue, in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effects of free fatty acids and acipimox, a lipolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effects of Recombinant Human Insulin-Like Growth Factor I Administration on Spontaneous and Growth Hormone (GH)-Releasing Hormone-Stimulated GH Secretion in Anorexia Nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

In vitro effect of human recombinant leptin and expression of leptin receptors on growth hormone-secreting human pituitary adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Hexarelin is a stronger GH-releasing peptide than GHRH in normal cycling women but not in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effect of exogenous growth hormone on glucose utilization in burn patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Reduced sulphation factor in undernourished children

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Weight-reducing effects of the plasma protein encoded by the obese gene

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Regulation of leptin production in cultured mature white adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Plasma somatomedin and growth hormone values in children with protein-calorie malnutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Metabolic actions of growth hormone in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Regulation of pulsatile growth hormone secretion by fasting in normal subjects and patients with acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

A receptor in pituitary and hypothalamus that functions in growth hormone release

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Intracerebroventricular injection of leptin increases thermogenesis and mobilizes fat metabolism in ob/ob mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Body water and sodium in patients with acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

The effect of glucose and free fatty acids on growth hormone (GH)-releasing factor-mediated GH secretion in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

The effect of free fatty acids on growth hormone (GH)-releasing hormone-mediated GH secretion in man

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-1, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beagles

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Osteoporosis and anorexia nervosa: relative role of endocrine alterations and malnutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Leptin and leptin receptor expression in normal and neoplastic human pituitary: evidence of a regulatory role for leptin on pituitary cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Divergent regulation of rat adipocyte GLUT1 and GLUT4 glucose transporters by GH

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

The release of leptin and its effect on hormone release from human pituitary adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

The growth hormone secretagogue receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

A 6-day intracerebroventricular infusion of the growth hormone-releasing peptide KP-102 stimulates food intake in both non-stressed and intermittently-stressed rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effects of long-term administration of recombinant bovine tumor necrosis factor-alpha on glucose metabolism and growth hormone secretion in steers

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Administration of recombinant bovine tumor necrosis factor-alpha affects intermediary metabolism and insulin and growth hormone secretion in dairy heifers

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Circadian rhythm of plasma leptin levels in upper and lower body obese women: influence of body fat distribution and weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Serum immunoreactive-leptin levels are increased in patients with Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Ghrelin and the hyposomatotropism of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

The Acute Leptin Response to GH

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Growth hormone or insulin-like growth factor I increases fat oxidation and decreases protein oxidation without altering energy expenditure in parenterally fed rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Metabolic modulation of the growth hormone-releasing activity of hexarelin in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Comparison among the effects of arginine, a nitric oxide precursor, isosorbide dinitrate and molsidomine, two nitric oxide donors, on hormonal secretions and blood pressure in man

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Growth hormone release following thyrotrophin-releasing hormone injection into patients with anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Plasma somatomedin-C in fasted and refed rats: close relationship with changes in liver somatogenic but not lactogenic binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effects of interleukin-1-beta, interleukin-6 and tumor necrosis factor-alpha, alone or in association with hexarelin or galanin, on growth hormone gene expression and growth hormone release from pig pituitary cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Growth Hormone (GH) Responses to the Hexapeptide GH-Releasing Peptide and GH-Releasing Hormone (GHRH) in the Cynomolgus Macaque: Evidence for Non-GHRH-Mediated Responses*

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Pre- and postprandial pyridostigmine and oxiracetam effects on growth hormone secretion in anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Study on the mechanism of abnormal growth hormone (GH) secretion in anorexia nervosa: no evidence of involvement of a low somatomedin-C level in the abnormal GH secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

The effect of glucose on growth hormone (GH)-releasing hormone-mediated GH secretion in man

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Insulin-like growth factors in the fed and fasted states.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Design, Synthesis, and Biological Activity of Peptides which Release Growth Hormone in Vitro*

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Kidney produces a novel acylated peptide, ghrelin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Growth hormone and the adipose conversion of 3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Ghrelin drives GH secretion during fasting in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Neuroendocrine control of growth hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Aspects of the neuroendocrine control of somatotropic function in calorically restricted dogs and patients with eating disorders: studies with cholinergic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Anorexia nervosa in female adolescents: endocrine and bone mineral density disturbances.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Growth hormone-binding protein in patients with anorexia nervosa determined in two assay systems

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Hyperglycaemia suppresses the secretion of ghrelin, a novel growth-hormone-releasing peptide: responses to the intravenous and oral administration of glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Responses of pituitary and adrenal medulla to insulin-induced hypoglycemia in patients with anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Long-term administration of acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Ghrelin immunoreactivity in human plasma is suppressed by somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Growth hormone and bone

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Intracerebroventricular administration of the growth hormone-releasing peptide KP-102 increases food intake in free-feeding rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effect of parenteral administration of selected nutrients and central injection of gamma-globulin from antiserum to neuropeptide Y on growth hormone secretory pattern in food-deprived rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Restoration of growth hormone secretion in prolonged food-deprived rats depends on the level of nutritional intake and dietary protein

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Plasma free fatty acid concentrations in obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Ghrelin-induced growth hormone secretion in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effects of the obese gene product on body weight regulation in ob/ob mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatost

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Somatostatin infusion withdrawal: studies in the acute and recovery phase of anorexia nervosa, and in obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

1 reference

7 January 2021

Role of interleukin-6 and transforming growth factor-β in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Identification of a new G-protein-linked receptor for growth hormone secretagogues

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Protein and energy metabolism with biosynthetic human growth hormone in patients on full intravenous nutritional support

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effect of acipimox, a lipid lowering drug, on growth hormone (GH) response to GH-releasing hormone in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH secretion in patients with anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Leptin inhibits in vitro hypothalamic somatostatin secretion and somatostatin mRNA levels

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Six-week treatment with hexarelin in young dogs: evaluation of the GH responsiveness to acute hexarelin or GHRH administration, and of the orexigenic effect of hexarelin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Visceral Adipose Tissue Is Associated with Circulating High Affinity Growth Hormone-Binding Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Failure of glucose infusion to suppress the exaggerated GH response to GHRH in patients with anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Corticotrophin-releasing hormone does not inhibit growth hormone-releasing hormone-induced release of growth hormone in control subjects but is effective in patients with eating disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

The effects of growth hormone on protein metabolism in adult growth hormone deficient patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Parallel studies of His-DTrp-Ala-Trp-DPhe-Lys-NH2 and human pancreatic growth hormone-releasing factor-44-NH2 in rat primary pituitary cell monolayer culture

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effect of thyrotropin-releasing hormone on growth hormone release in normal subjects pretreated with human pancreatic growth hormone-releasing factor 1-44 pulsatile administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effect of insulin on central catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Lack of growth hormone response to acute administration of dexamethasone in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Spontaneous nocturnal growth hormone secretion in anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Growth hormone in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Tumour necrosis factor production and cell-mediated immunityin anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

The effect of plasma glucose on the growth hormone response to human pancreatic growth hormone releasing factor in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Plasma GH responses to GHRH and insulin-induced hypoglycemia in man

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Intact leptin receptor is selectively expressed in human fetal pituitary and pituitary adenomas and signals human fetal pituitary growth hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Ultradian oscillations of leptin secretion in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Plasma Growth Hormone, Insulin, and Glucagon Responses to Arginine Infusion in Children and Adolescents with Idiopathic Short Stature, Isolated Growth Hormone Deficiency, Panhypopituitarism, and Anorexia Nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Serum insulin-like growth factors I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

The role of neuropeptide Y in the antiobesity action of the obese gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Indirect evidence for decreased hypothalamic somatostatinergic tone in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Low serum levels of free and total insulin-like growth factor I (IGF-I) in patients with anorexia nervosa are not associated with increased IGF-binding protein-3 proteolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Jointly amplified basal and pulsatile growth hormone (GH) secretion and increased process irregularity in women with anorexia nervosa: indirect evidence for disruption of feedback regulation within the GH-insulin-like growth factor I axis.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Diurnal variation of the serum leptin concentration in patients with anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Increased pituitary growth hormone-releasing factor (GRF) receptor messenger ribonucleic acid expression in food-deprived rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Ghrelin Strongly Stimulates Growth Hormone Release in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Responses of growth hormone and cortisol to intravenous glucose loading test in patients with anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effect of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(1-44)-induced GH secretion in anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Ghrelin stimulates GH but not food intake in arcuate nucleus ablated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Increased fasting plasma ghrelin levels in patients with bulimia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Mechanisms of impaired growth hormone secretion in genetically obese Zucker rats: roles of growth hormone-releasing factor and somatostatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effect of restricted feeding on the relationship between hypophysial portal concentrations of growth hormone (GH)-releasing factor and somatostatin, and jugular concentrations of GH in ovariectomized ewes.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Differential orexigenic effects of hexarelin and its analogs in the rat hypothalamus: indication for multiple growth hormone secretagogue receptor subtypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Upregulation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Ghrelin acts on leptin-responsive neurones in the rat arcuate nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Hypophysectomy prevents ghrelin-induced adiposity and increases gastric ghrelin secretion in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Ghrelin induces adiposity in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Post-prandial decrease of circulating human ghrelin levels

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Circulating ghrelin levels are decreased in human obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

The hormonal control of protein metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Effects of insulin-like growth factor-I (IGF-I), insulin and combined IGF-I-insulin infusions on protein metabolism in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Tumor necrosis factor-alpha and anorexia--cause or effect?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Triiodothyronine administration reduces serum growth hormone levels and growth hormone responses to thyrotropin-releasing hormone in patients with anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Dynamic neuroendocrine responses to critical illness

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Subcellular localization of leptin in non-tumorous and adenomatous human pituitaries: an immuno-ultrastructural study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Expression of Ghrelin and of the GH Secretagogue Receptor by Pancreatic Islet Cells and Related Endocrine Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

The role of endotoxin, TNF-alpha, and IL-6 in inducing the state of growth hormone insensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Ghrelin enhances appetite and increases food intake in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

The hypothalamic mechanisms of the hypophysiotropic action of ghrelin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Tumor necrosis factor mediates hepatic growth hormone resistance during sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

Positional cloning of the mouse obese gene and its human homologue

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3022%2803%2900014-1

7 January 2021

10.1016/S0091-3022(03)00014-1

Identifiers

DOI

1 reference

release_2uegvfrrhvhublye45sbxjqqwe

8 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2uegvfrrhvhublye45sbxjqqwe

24 November 2022

mapped directly with Wikidata item

1 reference